Eskag Pharma Pvt Ltd, a active private limited company, was established on 24 February 1977 in Kolkata, West Bengal, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24234WB1977PTC030897. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹1.80 Cr and a paid-up capital of ₹1.68 Cr.
It upholds a compliant status. Employing 594 professional, Its leadership includes Anil Kumar Agarwal (Director), Sunil Kumar Agarwal (Director). Past directors included Sushil Kumar Agarwal. It holds ₹104.71 Cr open charges and ₹35.15 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Ag - 112, Unit No - 4, 8Th Flooor Baisakhi, Sector - Ii, Saltlake, Kolkata, West Bengal, 700091.
U24234WB1977PTC030897
030897
24 February 1977
₹1.80 Cr
₹1.68 Cr
Roc Kolkata
Unlisted
Active
Explore comprehensive insights into Eskag Pharma Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anil Kumar Agarwal | Director | 11 May 2005 | Current |
| Sunil Kumar Agarwal | Director | 13 Jun 1984 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 21 Jun 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Eskag Pharma Pvt Ltd, for the financial year ended 2024, experienced modest growth in revenue, with a 0.12% increase. The company also saw a substantial fall in profitability, with a 30.54% decrease in profit. The company's net worth Soared by an impressive increase of 13.8%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Eskag Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,047,076,562.00
₹351,450,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Jan 2023 | Standard Chartered Bank | ₹15.00 Cr | Open |
| 28 Jun 2021 | Standard Chartered Bank | ₹17.57 Cr | Open |
| 21 Jan 2020 | Hdfc Bank Limited | ₹55.45 Cr | Open |
| 29 Dec 2018 | Others | ₹4.45 M | Open |
| 02 Feb 2018 | Hdfc Bank Limited | ₹13.40 Cr | Open |
Explore comprehensive loan charge details -
Eskag Pharma has a workforce of 594 employees as of Mar 04, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Eskag Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eskag Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Eskag Pharma Pvt Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Eskag Pharma Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kolkata. was documented.
Progress on A charge with Standard Chartered Bank of Rs. 17.57 Cr registered on 28 Jun 2021 with Charge ID 100457268 was modified on 17 May 2023. was documented.
A charge with Standard Chartered Bank amounted to Rs. 15.00 Cr with Charge ID 100665623 was registered on 04 Jan 2023. was recorded as a recent event.
Progress on A charge with Hdfc Bank Limited of Rs. 55.45 Cr registered on 21 Jan 2020 with Charge ID 100322930 was modified on 09 Nov 2022. was documented.
A charge registered on 28 Jul 2017 via Charge ID 100118027 with Others was fully satisfied on 21 Feb 2022. was recorded as a recent event.
The CIN of Eskag Pharma Pvt Ltd is U24234WB1977PTC030897.
Eskag Pharma Pvt Ltd is headquartered at Ag - 112, Unit No - 4, 8Th Flooor Baisakhi, Sector - Ii, Saltlake, Kolkata, West Bengal, 700091.
Eskag Pharma Pvt Ltd was incorporated on 24 February 1977.
The current directors of Eskag Pharma Pvt Ltd are
The primary industry of Eskag Pharma Pvt Ltd is Manufacturing.
Eskag Pharma Pvt Ltd is unlisted.
The authorized capital of Eskag Pharma Pvt Ltd is ₹1.80 Cr, and the paid-up capital is ₹1.68 Cr.
The compliance status of Eskag Pharma Pvt Ltd is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX